A comprehensive view of Mallinckrodt PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis buys Mallinckrodt’s FDA priority review voucher for US$100M to speed up future FDA drug applications; voucher shortens FDA’s drug review process from 10 months to six months

Mallinckrodt announces U.S. Bankruptcy Court confirmation of the company's announced reorganization plan; process will reduce debt, address litigation claims

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count